Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure:: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4

被引:55
作者
Lewis, DFV [1 ]
Lake, BG
Dickins, M
Eddershaw, PJ
Tarbit, MH
Goldfarb, PS
机构
[1] Univ Surrey, Sch Biol Sci, Mol Toxicol Grp, Guildford GU2 5XH, Surrey, England
[2] BIBRA Int, Carshalton SM5 4DS, Surrey, England
[3] Glaxo Wellcome Res & Dev Ltd, Ware SG12 0DP, Herts, England
关键词
D O I
10.1080/004982599238560
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Molecular modelling studies of CYP2B isoforms from rat (CYP2B1), rabbit (CYP2B4) and man (CYP2B6) are reported, with particular emphasis on substrate interactions with the human CYP2B isoform, CYP2B6. 2. The findings represent an advance on our previous study that focused primarily on the rat CYP2B isoform, CYP2B1, and involved homology modelling with substrate-free CYP102. 3. The current work utilizes the recently published substrate-bound CYP102 crystal structure as a template for construction of the CYP2B subfamily isoforms and shows, in particular, that known CYP2B6 substrate specificity and regioselectivity can be rationalized by putative active site interactions.
引用
收藏
页码:361 / 393
页数:33
相关论文
共 106 条
[1]  
AOYAMA T, 1989, J BIOL CHEM, V264, P21327
[2]  
Archakov A.I., 1990, CYTOCHROME P450 ACTI
[3]  
BAKER MT, 1995, DRUG METAB DISPOS, V23, P60
[4]   7-ETHOXYCOUMARIN O-DEETHYLASE KINETICS IN ISOLATED RAT, DOG AND HUMAN HEPATOCYTE SUSPENSIONS [J].
BAYLISS, MK ;
BELL, JA ;
WILSON, K ;
PARK, GR .
XENOBIOTICA, 1994, 24 (03) :231-241
[5]  
BENRHARDT R, 1989, CYTOCHROME P450 BIOC, P320
[6]   Cytochrome P450: Structure, function, and generation of reactive oxygen species [J].
Bernhardt, R .
REVIEWS OF PHYSIOLOGY BIOCHEMISTRY AND PHARMACOLOGY, VOL 127, 1996, 127 :137-221
[7]   CORRELATIONS BETWEEN SPIN EQUILIBRIUM SHIFT, REDUCTION RATE, AND N-DEMETHYLATION ACTIVITY IN LIVER MICROSOMAL CYTOCHROME-P-450 AND A SERIES OF BENZPHETAMINE ANALOGS AS SUBSTRATES [J].
BLANCK, J ;
REIN, H ;
SOMMER, M ;
RISTAU, O ;
SMETTAN, G ;
RUCKPAUL, K .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (11) :1683-1688
[8]  
BORN SL, 1995, DRUG METAB DISPOS, V23, P702
[9]  
CAMOLLE GP, 1996, ISSX P 7 N AM ISSX M, V10, P361
[10]  
CHANG TKH, 1993, CANCER RES, V53, P5629